Opinion on  Genta Inc. (GNTA)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Genta

On december 15th Genta Receives Non-Approvable Notice for Application of Genasense in Patients With Chronic Lymphocytic Leukemia, Decmber 20th - Genta Restructures Operations to Focus on Future Initiatives (company has reduced its workforce by 34 people, or approximately 35%).



Currently Genasense marketing applications are currently under review by regulatory authorities in the United States and in Europe. Genta is actively evaluating opportunities to license, co-develop or acquire additional compounds, as well as companies that complement their oncolgy development expertise. Drug approval takes forever, but when it is approved company's stock goes up sharply.



I am adding this stock to my portfolio in hopes on receiving over 50% return, or loosing every single penny (don't bet too much money on it)

I sold GNTA today to buy even more Ask Me Now, Inc. (AKMN) stock at 0.74.

I know that's a bad example I am showing and should be punished for, however I believe that at this point of time Ask Me Now will move faster then GNTA, plus right now GNTA is in the bear mode for another 3 month.

Congrats to those who with me made 8% in a week.